FTY720通过中性粒细胞PPARα-CPT1a通路调控脂肪酸氧化改善实验性MPO-ANCA相关性血管炎
本研究在实验性自身免疫性血管炎(EAV)模型中评估S1P受体调节剂FTY720的疗效,并探讨其通过中性粒细胞免疫代谢调控ANCA诱导的中性粒细胞活化的机制。FTY720显著减轻EAV肾脏损伤和肺出血,RNA测序显示治疗组肾皮质脂肪酸氧化(FAO)和PPAR信号增强;活动性AAV患者中性粒细胞FAO较正常对照降低,阻断或敲低CPT1a或PPARα可逆转FTY720对ANCA诱导的呼吸爆发和NETosis的抑制作用。
要点
- FTY720治疗显著减轻EAV大鼠的肾脏损伤和肺出血。
- FTY720上调中性粒细胞PPARα-CPT1a通路促进脂肪酸氧化。
- 活动性AAV患者中性粒细胞脂肪酸氧化较正常对照降低。
核心结论
- FTY720通过上调中性粒细胞PPARα-CPT1a通路促进脂肪酸氧化,从而减轻EAV肾脏损伤,为AAV治疗提供潜在免疫代谢靶点。
研究设计与样本
- 研究在实验性自身免疫性血管炎(EAV)模型中评估FTY720疗效,并对肾皮质进行RNA测序和基因富集分析。
- 在外周血中性粒细胞(活动性AAV患者与正常对照)及HL-60细胞中分析关键通路蛋白并评估FTY720对ANCA诱导的呼吸爆发和NETosis的影响。
主要发现
- FTY720治疗显著减轻EAV的肾脏损伤和肺出血。
- 肾皮质RNA测序显示FTY720治疗大鼠脂肪酸氧化(FAO)和过氧化物酶体增殖物激活受体(PPAR)信号增强。
- 与正常对照相比,活动性AAV患者中性粒细胞FAO降低。
- FTY720处理的分化HL-60细胞中肉碱棕榈酰转移酶1a(CPT1a)和PPARα表达增加。
- 在分离的人中性粒细胞和HL-60细胞中阻断或敲低CPT1a或PPARα,可逆转FTY720对ANCA诱导的中性粒细胞呼吸爆发和NETosis的抑制作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Increasing studies demonstrated the importance of C5a and anti-neutrophil cytoplasmic antibody (ANCA)-induced neutrophil activation in the pathogenesis of ANCA-associated vasculitis (AAV). Sphingosine-1-phosphate (S1P) acts as a downstream effector molecule of C5a and enhances neutrophil activation induced by C5a and ANCA. The current study investigated the role of a S1P receptor modulator, FTY720, in experimental autoimmune vasculitis (EAV) and explored the immunometabolism-related mechanisms of FTY720 in modulating ANCA-induced neutrophil activation. METHODS: The effects of FTY720 in EAV were evaluated by quantifying haematuria, proteinuria, crescent formation, tubulointerstitial injury and pulmonary haemorrhage. RNA sequencing of renal cortex and gene enrichment analysis were performed. The proteins of key identified pathways were analysed in neutrophils isolated from peripheral blood of patients with active AAV and normal controls. We assessed the effects of FTY720 on ANCA-induced neutrophil respiratory burst and neutrophil extracellular traps formation (NETosis). RESULTS: FTY720 treatment significantly attenuated renal injury and pulmonary haemorrhage in EAV. RNA sequencing analyses of renal cortex demonstrated enhanced fatty acid oxidation (FAO) and peroxisome proliferator-activated receptor (PPAR) signalling in FTY720-treated rats. Compared with normal controls, patients with active AAV showed decreased FAO in neutrophils. FTY720-treated differentiated HL-60 cells showed increased expression of carnitine palmitoyltransferase 1a (CPT1a) and PPARα. Blocking or knockdown of CPT1a or PPARα in isolated human neutrophils and HL-60 cells reversed the inhibitory effects of FTY720 on ANCA-induced neutrophil respiratory burst and NETosis. CONCLUSION: FTY720 attenuated renal injury in EAV through upregulating FAO via the PPARα-CPT1a pathway in neutrophils, offering potential immunometabolic targets in AAV treatment.
引用
- Wang RX, Wang LY, Han XY, et al. FTY720 ameliorates experimental MPO-ANCA-associated vasculitis by regulating fatty acid oxidation via the neutrophil PPARα-CPT1a pathway. Rheumatology (Oxford). 2024. PMID: 38837706. doi:10.1093/rheumatology/keae320
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。